Inventor · disambiguated record
Steven Swallow
Also filed as: SWALLOW STEVEN
24 granted patents·12 pending applications·235 citations·filing 2001–2025
97Inventor score
Files withASTRAZENECA AB28ROCHE PALO ALTO LLC3HOFFMANN LA ROCHE2BROWN DEARG SUTHERLAND1FAULL ALAN WELLINGTON1
Top patents by PatentIndex Score
36 records- 0198US12054465B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Granted Aug 6, 2024·3 cites·21 claims
- 0298US11814359B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Nov 14, 2023·4 cites·21 claims
- 0398US11773069B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Oct 3, 2023·6 cites·23 claims
- 0498US11680049B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 20, 2023·5 cites·14 claims
- 0598US11117874B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2020·Granted Sep 14, 2021·15 cites·60 claims
- 0698US10669245B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2019·Granted Jun 2, 2020·16 cites·16 claims
- 0798US9815805B2Certain (25)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2016·Granted Nov 14, 2017·22 cites·14 claims
- 0897US11673871B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·20 claims
- 0997US11673872B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·14 claims
- 1097US11667615B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2021·Granted Jun 6, 2023·5 cites·15 claims
- 1197US11655222B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1297US11655221B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·22 claims
- 1397US11655223B2Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·21 claims
- 1497US11655224B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1597US10287258B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2017·Granted May 14, 2019·18 cites·6 claims
- 1697US9522894B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2015·Granted Dec 20, 2016·25 cites·8 claims
- 1792US7189718B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2004·Granted Mar 13, 2007·33 cites·40 claims
- 1891US7348345B2Nonnucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2007·Granted Mar 25, 2008·8 cites·7 claims
- 1991US7208509B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2004·Granted Apr 24, 2007·26 cites·33 claims
- 2091US2024336582A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 2187US2023250071A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 2283US2024041896A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 2377US9902731B2Chemical compoundsASTRAZENECA AB·Filed 2016·Granted Feb 27, 2018·2 cites·19 claims
- 2477US2022133737A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2022·Application pending·0 cites
- 2574US2025228870A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2025·Application pending·0 cites
- 2673US7241794B2Nonnucleoside reverse transcriptase inhibitorsROCHEPALO ALTO LLC·Filed 2004·Granted Jul 10, 2007·13 cites·5 claims
- 2769US6472404B1HIV protease inhibitorsHOFFMANN LA ROCHE·Filed 2001·Granted Oct 29, 2002·4 cites·17 claims
- 2868US2018028541A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors for treating bronchiectasisASTRAZENECA AB·Filed 2017·Application pending·0 cites
- 2966US2020179398A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2019·Application pending·0 cites
- 3065US2019091236A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasisASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 3157US2008139612A1Chemical CompoundASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 3256US2010099708A1Piperidine Derivative Used for Treating Chemokine Receptor 5 Mediated DiseasesFAULL ALAN WELLINGTON·Filed 2007·Application pending·0 cites
- 3356US2008139613A1Chemical CompoundASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 3456US2010093795A1Piperidine Derivative Used for Treating Chemokine Receptor 5 Mediated DiseasesBROWN DEARG SUTHERLAND·Filed 2007·Application pending·0 cites
- 3555US10202391B2Chemical compoundsASTRAZENECA AB·Filed 2018·Granted Feb 12, 2019·0 cites·3 claims
- 3644US6632826B1Carbocyclic HIV protease inhibitorsHOFFMANN LA ROCHE·Filed 2002·Granted Oct 14, 2003·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Steven Swallow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →